HLA-haploidentical T cell-depleted allogeneic hematopoietic stem cell transplantation in children with fanconi anemia

Biology of Blood and Marrow Transplantation

Volumn 20, Issue 4, 2014, Pages 571-576

  Zecca, Marco ^a   Strocchio, Luisa ^a   Pagliara, Daria ^b   Comoli, Patrizia ^a   Bertaina, Alice ^b   Giorgiani, Giovanna ^a   Perotti, Cesare ^a   Corbella, Franco ^a   Brescia, Letizia ^b   Locatelli, Franco ^b,c  

^a FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^b BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^c UNIVERSITY OF PAVIA   (Italy)

Author keywords

Fanconi anemia; Haploidentical stem cell transplantation; Reduced intensity conditioning; Tcell depletion

Indexed keywords

ASPARAGINASE; BUTADIENE DIEPOXIDE; CYTARABINE; DEXAMETHASONE; DOXORUBICIN; EPSTEIN BARR VIRUS ANTIGEN; FLUDARABINE; GRANULOCYTE COLONY STIMULATING FACTOR; HLA A ANTIGEN; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; HLA B ANTIGEN; HLA C ANTIGEN; HLA DR ANTIGEN; IMMUNOGLOBULIN G; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR; PROTEIN P53; VIRUS CAPSID ANTIGEN;

ACUTE GRAFT VERSUS HOST DISEASE; ACUTE GRANULOCYTIC LEUKEMIA; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ALLOIMMUNITY; ARTICLE; BLADDER DISEASE; CANDIDA ALBICANS; CANDIDEMIA; CAUSE OF DEATH; CHILD; CHILDHOOD DISEASE; CHIMERA; CHROMOSOME 17P; CHROMOSOME 5Q; CHROMOSOME BREAKAGE; CHROMOSOME DELETION; CHRONIC GRAFT VERSUS HOST DISEASE; CLINICAL ARTICLE; CLONAL EVOLUTION; DISEASE FREE SURVIVAL; DONOR SELECTION; ERYTHROCYTE TRANSFUSION; EVENT FREE SURVIVAL; FANCONI ANEMIA; FEMALE; FOLLOW UP; GASTROINTESTINAL TOXICITY; GENE LOCUS; GRAFT REJECTION; GRAFT VERSUS HOST REACTION; HAPLOTYPE; HLA MATCHING; HLA SYSTEM; HUMAN; KARYOTYPE; LEUKAPHERESIS; LEUKEMIA REMISSION; LOW DRUG DOSE; LUNG TOXICITY; MALE; MEDIASTINUM MASS; MOLECULAR TYPING; MORTALITY; MULTIPLE CYCLE TREATMENT; MYELODYSPLASTIC SYNDROME; NATURAL KILLER CELL; NONHODGKIN LYMPHOMA; OPPORTUNISTIC INFECTION; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PERIPHERAL BLOOD STEM CELL; PRESCHOOL CHILD; REDUCED INTENSITY CONDITIONING; RESPIRATORY FAILURE; RESPIRATORY SYNCYTIAL VIRUS INFECTION; SCHOOL CHILD; SHORT TANDEM REPEAT; T CELL DEPLETION; T LYMPHOCYTE; THROMBOCYTE TRANSFUSION; TRANSPLANT RELATED MORTALITY;

FANCONI ANEMIA; HAPLOIDENTICAL STEM CELL TRANSPLANTATION; REDUCED-INTENSITY CONDITIONING; T CELL DEPLETION;

ADOLESCENT; ANTIGENS, CD34; CHILD; FANCONI ANEMIA; FEMALE; GRAFT SURVIVAL; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOCOMPATIBILITY TESTING; HLA ANTIGENS; HUMANS; LYMPHOCYTE DEPLETION; MALE; MYELOABLATIVE AGONISTS; PROSPECTIVE STUDIES; SURVIVAL ANALYSIS; T-LYMPHOCYTES; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME; UNRELATED DONORS; VIDARABINE;

EID: 84895783429     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2014.01.015     Document Type: Article

References (49)

1. Fanconi G. Familial constitutional panmyelocytopathy, Fanconi's anemia (F.A.). I. Clinical aspects. Semin Hematol 1967, 4:233-240.
2. Schroeder T.M., Tilgen D., Kruger J., Vogel F. Formal genetics of Fanconi's anemia. Hum Genet 1976, 32:257-288.
3. Bessler M., Mason P.J., Link D.C., Wilson D.B. Inherited bone marrow failure syndromes. Nathan and Oski's hematology of infancy and childhood 2009, vol. 1:307-397. Saunders, Philadelphia.
4. Butturini A., Gale R.P., Verlander P.C., et al. Hematologic abnormalities in Fanconi anemia: an International Fanconi Anemia Registry study. Blood 1994, 84:1650-1655.
5. Alter B.P. Fanconi's anemia and malignancies. Am J Hematol 1996, 53:99-110.
6. Mehta P., Locatelli F., Stary J., Smith F.O. Bone marrow transplantation for inherited bone marrow failure syndromes. Pediatr Clin North Am 2010, 57:147-170.
7. Soulier J. Fanconi anemia. Hematol Am Soc Hematol Educ Progr 2011, 2011:492-497.
8. Kee Y., D'Andrea A.D. Molecular pathogenesis and clinical management of Fanconi anemia. JClin Invest 2012, 122:3799-3806.
9. Kee Y., D'Andrea A.D. Expanded roles of the Fanconi anemia pathway in preserving genomic stability. Genes Dev 2010, 24:1680-1694.
10. Bogliolo M., Schuster B., Stoepker C., et al. Mutations in ERCC4, encoding the DNA-repair endonuclease XPF, cause Fanconi anemia. Am J Hum Genet 2013, 92:800-806.
11. Eiler M, Frohnmayer, D, Frohnmayer, L, etal., eds. Fanconi anemia: guidelines for diagnosis and management, 3rd ed., Eugene, Oregon, 2008.
12. Gluckman E., Devergie A., Schaison G., et al. Bone marrow transplantation in Fanconi anaemia. Br J Haematol 1980, 45:557-564.
13. Gluckman E., Devergie A., Dutreix J. Radiosensitivity in Fanconi anaemia: application to the conditioning regimen for bone marrow transplantation. Br J Haematol 1983, 54:431-440.
14. Gluckman E., Auerbach A.D., Horowitz M.M., et al. Bone marrow transplantation for Fanconi anemia. Blood 1995, 86:2856-2862.
15. Medeiros C., Zanis-Neto J., Pasquini R. Bone marrow transplantation for patients with Fanconi anemia: reduced doses of cyclophosphamide without irradiation as conditioning. Bone Marrow Transplant 1999, 24:849-852.
16. Peffault de Latour R., Porcher R., Dalle J.H., et al. Allogeneic hematopoietic stem cell transplantation in Fanconi anemia: the EBMT experience. Blood 2013, 122:4279-4286.
17. Fischer A., Friedrich W., Fasth A., et al. Reduction of graft failure by a monoclonal antibody (anti-LFA-1 CD11a) after HLA nonidentical bone marrow transplantation in children with immunodeficiencies, osteopetrosis, and Fanconi's anemia: a European Group for Immunodeficiency/European Group for Bone Marrow Transplantation report. Blood 1991, 77:249-256.
18. Boulad F., Gillio A., Small T.N., et al. Stem cell transplantation for the treatment of Fanconi anaemia using a fludarabine-based cytoreductive regimen and T-cell-depleted related HLA-mismatched peripheral blood stem cell grafts. Br J Haematol 2000, 111:1153-1157.
19. Elhasid R., Ben Arush M.W., Katz T., et al. Successful haploidentical bone marrow transplantation in Fanconi anemia. Bone Marrow Transplant 2000, 26:1221-1223.
20. Rossi G., Giorgiani G., Comoli P., et al. Successful T-cell-depleted, related haploidentical peripheral blood stem cell transplantation in a patient with Fanconi anaemia using a fludarabine-based preparative regimen without radiation. Bone Marrow Transplant 2003, 31:437-440.
21. Motwani J., Lawson S.E., Darbyshire P.J. Successful HSCT using nonradiotherapy-based conditioning regimens and alternative donors in patients with Fanconi anaemia-experience in a single UK centre. Bone Marrow Transplant 2005, 36:405-410.
22. Yabe H., Inoue H., Matsumoto M., et al. Unmanipulated HLA-haploidentical bone marrow transplantation for the treatment of fatal, nonmalignant diseases in children and adolescents. Int J Hematol 2004, 80:78-82.
23. Locatelli F., Zecca M., Pession A., et al. The outcome of children with Fanconi anemia given hematopoietic stem cell transplantation and the influence of fludarabine in the conditioning regimen: a report from the Italian pediatric group. Haematologica 2007, 92:1381-1388.
24. Rihani R., Lataifeh I., Halalsheh H., et al. Haploidentical stem cell transplantation as a salvage therapy for cord blood engraftment failure in a patient with Fanconi anemia. Pediatr Blood Cancer 2010, 55:580-582.
25. Dufort G., Pisano S., Incoronato A., et al. Feasibility and outcome of haploidentical SCT in pediatric high-risk hematologic malignancies and Fanconi anemia in Uruguay. Bone Marrow Transplant 2012, 47:663-668.
26. Thakar M.S., Bonfim C., Sandmaier B.M., et al. Cyclophosphamide-based invivo T-cell depletion for HLA-haploidentical transplantation in Fanconi anemia. Pediatr Hematol Oncol 2012, 29:568-578.
27. Moretta A., Locatelli F., Moretta L. Human NK cells: from HLA class I-specific killer Ig-like receptors to the therapy of acute leukemias. Immunol Rev 2008, 224:58-69.
28. Stern M., Ruggeri L., Mancusi A., et al. Survival after T cell-depleted haploidentical stem cell transplantation is improved using the mother as donor. Blood 2008, 112:2990-2995.
29. Glucksberg H., Storb R., Fefer A., et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation 1974, 18:295-304.
30. Shulman H.M., Sullivan K.M., Weiden P.L., et al. Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. Am J Med 1980, 69:204-217.
31. Bearman S.I., Appelbaum F.R., Buckner C.D., et al. Regimen-related toxicity in patients undergoing bone marrow transplantation. JClin Oncol 1988, 6:1562-1568.
32. Kaplan E., Meier P. Nonparametric estimation from incomplete observations. JAm Stat Assoc 1958, 53:457-481.
33. Gooley T.A., Leisenring W., Crowley J., Storer B.E. Estimation of failure probabilities in the presence of competing risks: new representations of old estimators. Stat Med 1999, 18:695-706.
34. Pepe M.S., Longton G., Pettinger M., et al. Summarizing data on survival, relapse, and chronic graft-versus-host disease after bone marrow transplantation: motivation for and description of new methods. Br J Haematol 1993, 83:602-607.
35. Scrucca L., Santucci A., Aversa F. Competing risk analysis using R: an easy guide for clinicians. Bone Marrow Transplant 2007, 40:381-387.
36. Scrucca L., Santucci A., Aversa F. Regression modeling of competing risk using R: an in depth guide for clinicians. Bone Marrow Transplant 2010, 45:1388-1395.
37. Pennings G., Schots R., Liebaers I. Ethical considerations on preimplantation genetic diagnosis for HLA typing to match a future child as a donor of haematopoietic stem cells to a sibling. Hum Reprod 2002, 17:534-538.
38. Rocha V., Locatelli F. Searching for alternative hematopoietic stem cell donors for pediatric patients. Bone Marrow Transplant 2008, 41:207-214.
39. MacMillan M.L., Wagner J.E. Haematopoeitic cell transplantation for Fanconi anaemia-when and how?. Br J Haematol 2010, 149:14-21.
40. Reisner Y., Hagin D., Martelli M.F. Haploidentical hematopoietic transplantation: current status and future perspectives. Blood 2011, 118:6006-6017.
41. Champlin R.E., Passweg J.R., Zhang M.J., et al. T-cell depletion of bone marrow transplants for leukemia from donors other than HLA-identical siblings: advantage of T-cell antibodies with narrow specificities. Blood 2000, 95:3996-4003.
42. Chaudhury S., Auerbach A.D., Kernan N.A., et al. Fludarabine-based cytoreductive regimen and T-cell-depleted grafts from alternative donors for the treatment of high-risk patients with Fanconi anaemia. Br J Haematol 2008, 140:644-655.
43. Aversa F., Tabilio A., Terenzi A., et al. Successful engraftment of T-cell-depleted haploidentical "three-loci" incompatible transplants in leukemia patients by addition of recombinant human granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cells to bone marrow inoculum. Blood 1994, 84:3948-3955.
44. Reisner Y., Martelli M.F. Transplantation tolerance induced by "mega dose" CD34+ cell transplants. Exp Hematol 2000, 28:119-127.
45. Ruggeri L., Capanni M., Urbani E., et al. Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants. Science 2002, 295:2097-2100.
46. Ruggeri L., Capanni M., Casucci M., et al. Role of natural killer cell alloreactivity in HLA-mismatched hematopoietic stem cell transplantation. Blood 1999, 94:333-339.
47. Guardiola P., Socie G., Li X., et al. Acute graft-versus-host disease in patients with Fanconi anemia or acquired aplastic anemia undergoing bone marrow transplantation from HLA-identical sibling donors: risk factors and influence on outcome. Blood 2004, 103:73-77.
48. Zecca M., Prete A., Rondelli R., et al. Chronic graft-versus-host disease in children: incidence, risk factors, and impact on outcome. Blood 2002, 100:1192-1200.
49. Guardiola P., Pasquini R., Dokal I., et al. Outcome of 69 allogeneic stem cell transplantations for Fanconi anemia using HLA-matched unrelated donors: a study on behalf of the European Group for Blood and Marrow Transplantation. Blood 2000, 95:422-429.